The depositions of amyloid-beta peptide, a product of the cleavage of the amyloid-beta protein precursor, and the abnormal tau protein can be used as diagnostic markers for AD (Holtzman et al., 2011). The gene discussed is MAPT; the disease is Alzheimer disease.